Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

INO

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc New
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:INO
일자시간출처헤드라인심볼기업
2024/06/0105:48PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2905:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1705:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1406:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405:05PR Newswire (US)INOVIO Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/0121:00PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
2024/04/2921:00PR Newswire (US)INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024NASDAQ:INOInovio Pharmaceuticals Inc New
2024/04/2921:00PR Newswire (US)INOVIO to Participate in Upcoming Investor Conferences in MayNASDAQ:INOInovio Pharmaceuticals Inc New
2024/04/1607:39PR Newswire (US)INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:INOInovio Pharmaceuticals Inc New
2024/03/2707:28PR Newswire (US)INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn MedicineNASDAQ:INOInovio Pharmaceuticals Inc New
 검색 관련기사 보기:NASDAQ:INO